ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Young Investigator Award 2026: Development of a reconstructed induced pluripotent stem cell-derived immunocompetent skin model.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin sensitization testing is moving towards human-relevant, non-animal approaches, yet many current in vitro methods address only individual key events of the adverse outcome pathway. Here, a reconstructed immunocompetent human skin model is presented, generated entirely from induced pluripotent stem cell-derived fibroblasts, keratinocytes, and dendritic cells. The model reproduced key structural features of human skin and enabled the combined assessment of keratinocyte activation and dendritic-cell maturation and migration following topical exposure to skin sensitizers. By integrating epidermal and immune responses within a single three-dimensional skin construct, this model provides a mechanistically informative platform for skin sensitization research and supports the development of ethically responsible testing strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.